Urigen Pharmaceuticals, Inc. Provides Corporate Update
BURLINGAME, Calif.--(BUSINESS WIRE)--Urigen Pharmaceuticals, Inc., (OTCBB: URGP, www.urigen.com), a specialty pharmaceutical company focused on the development and commercialization of treatments for urological disorders, reports on its recent corporate developments. The company filed its Quarterly Report Form 10Q with the SEC on November 14, 2007.